Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post GOP senators express ‘concerns,’ ‘skepticism’ over Trump’s spending bill after Musk rant June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts Offer Booklet – Non-Renounceable Entitlement Offer June 6, 2025 Justin Huhn: Uranium Game On — Supply “Mirage,” De-risked Demand, Next Price Move June 6, 2025 Should You Invest in Silver Bullion? June 6, 2025